Mariana Pereira Address: Av. Brigadeiro Faria Lima, 3477 - 11th floor, Ipanema, Rio de Janeiro, RJ - Brazil - CEP 22430-000 NY Representative: MZ Group - Greg Falesnik Telephone: 1-949-385-6449 E-mail: greg.falesnik@mzgroup.us Thank you for your interest in Profarma. Please let us know if you need any additional information. Best regards, Profarma Investor Relations 18

1. 1Q10 Earnings Release
May, 13th, 2010.

2. 1Q10 Earnings Release
Highlights For The Period
• Gross revenue reached R$ 766.0 million, showing a 15.8% growth when comparing with the same period of the
previous year;
• Net profit of the Company increased 15.1% in relation to the same period of the previous year, reaching R$ 7.8
million, representing a net margin of 1.2%;
• A 7.8% reduction of the operating expenses, reaching 7.5% of the net operating revenue, representing a reduction
of 0.7 percentage point in relation with the same period of the previous year;
• Improvement of the service level, reaching 92.3%, an increase of 1.6 percentage point in relation to the same period
of the previous year when we reached 90.7%;
• Increase of the annual price occurred on March 31st, 2010 was of 4.5% in line with inflation accumulated in the past
12 months, being the second largest increase in the last four years.

3. 1Q10 Earnings Release
Gross Revenues Evolution
(R$ million)
807.4
766.0
661.8
1Q09 4Q09 1Q10
3

4. 1Q10 Earnings Release
Gross Revenues Breakdown
(R$ Million) 1Q10 1Q09 Chg. % 4Q09 Chg. %
Branded 511.7 453.9 12.7% 546.3 -6.3%
Generic 51.6 29.5 74.6% 50.8 1.6%
OTC 148.4 129.3 14.7% 157.1 -5.5%
Health and Beauty Products 26.8 23.2 15.4% 26.2 2.0%
Hospitals and Vaccines 27.6 25.8 7.0% 27.1 1.9%
Total 766.0 661.8 15.8% 807.4 -5.1%
4

5. 1Q10 Earnings Release
Market Share Evolution (%)
11.7 11.6*
11.5
10.9* 10.9*
9.6 9.6 9.9
2005 2006 2007 2008 2009 1Q09 4Q09 1Q10
*Excluding the similar’s effect
Source: IMS
5

6. 1Q10 Earnings Release
Gross Profit and Revenues from Services to Suppliers
(R$ million and as % Net Revenues)
11.2% 11.0%
10.4%
18.6
5.3
20.0
57.8
57.1
46.5
1Q09 4Q09 1Q10
Gross Profit Revenues from Services to Suppliers Gross Profit Margin (%)
6

7. 1Q10 Earnings Release
Operating Expenses
(R$ million and as % Net Revenues )
8.2%
7.4% 7.5%
50.6
48.1
45.9
1Q09 4Q09 1Q10
7

8. 1Q10 Earnings Release
Net Financial Expenses
(R$ million and as % Net Revenues)
1.4%
0.8% 0.8%
7.8
5.3 5.4
1Q09 4Q09 1Q10
8

9. 1Q10 Earnings Release
Net Profit
(R$ million and as % Net Revenues)
2.2%
1.2% 1.2%
15.4
7.8
6.7
1Q09 4Q09 1Q10
9

10. 1Q10 Earnings Release
Ebitda and Ebitda Margin
(R$ million and as % Net Revenues)
4.1%
3.0% 2,8%
28.0
17.9
17.1
1Q09 4Q09 1Q10
10

11. 1Q10 Earnings Release
CASH FLOW
(R$ Million) 1Q10 1Q09 Chg. % 4Q09 Chg. %
Cash Flow Generated / (Used) in Operating Activities (43.2) 36.6 - (19.2) -125.3%
Internal Cash Generation 18.6 12.8 44.6% 23.7 -21.6%
Operating Assets Variation (61.8) 23.8 - (42.9) -44.2%
Trade Accounts Receivable (1.8) 51.5 - (25.1) 92.9%
Inventories (18.7) 4.4 - (84.1) 77.8%
Suppliers (38.9) (22.0) -76.8% 102.0 -
Other Items (2.5) (10.2) 75.8% (35.8) 93.1%
Cash Flow (Used) in Investing Activities (1.5) (3.3) 56.1% (3.6) 59.0%
Cash Flow Generated / (Used) by Financing Activities 69.2 (6.2) - (9.9) -
Net Increase / (Decrease) in Cash 24.5 27.1 -9.4% (32.6) -
11

12. 1Q10 Earnings Release
3Q06 4Q06 1Q07 2Q07 3Q07 4Q07 1Q08 2Q08 3Q08 4Q08 1Q09 2Q09 3Q09 4Q09 1Q10
Cash Cycle – Days * 49.3 53.4 62.5 69.6 67.8 64.3 68.8 67.2 61.8 65.8 67.9 58.7 51.6 52.7 64.9
Accounts Receivable (1) 45.2 50.0 54.6 53.1 50.9 51.7 50.7 49.2 47.0 45.9 42.4 40.5 38.4 41.1 43.4
Inventories (2) 33.1 44.7 43.4 47.2 41.3 48.6 47.9 45.7 42.5 49.9 61.6 52.4 43.7 53.9 59.9
Accounts Payable (3) 29.0 41.3 35.6 30.7 24.5 36.0 29.8 27.7 27.7 29.9 36.1 34.3 30.5 42.3 38.4
* Average
(1) Average of Gross Revenues in the Quarter (2) Average of COGS in the Quarter (3) Average of COGS in the Quarter
12

13. 1Q10 Earnings Release
Indebtedness: Net Debt and Net Debt / Ebitda*
(R$ million)
1.6x
1.5x
1.1x
167.3
128.0
118.1
1Q09 4Q09 1Q10
* Ebitda = Accumulated last 12 months
13

14. 1Q10 Earnings Release
Capex
(R$ million and as % Net Revenues)
0.6% 0.5%
0.2%
3.7
3.3
1.5
1Q09 4Q09 1Q10
14

15. 1Q10 Earnings Release
Operating Indicators
Service Level Logistics E.P.M.
(units served / units requested) (Errors per Million)
210.0
93.0%
92.3%
130.0
95.0
90.7%
1Q09 4Q09 1Q10 1Q09 4Q09 1Q10
15

16. 1Q10 Earnings Release
Profarma vs Ibovespa 1Q10
140
120
112
103
100
80
60
12/30/09 01/09/10 01/19/10 01/29/10 02/08/10 02/18/10 02/28/10 03/10/10 03/20/10 03/30/10
Ibovespa Profarma
16

17. 1Q10 Earnings Release
Analyst Coverage
Firm Analyst
Javier Martinez de Olcoz Cerdan
Morgan Stanley Phone: (1 212) 761-4542
E-mail: javier.martinez.olcoz@morganstanley.com
Alexandre Pizano
Merrill Lynch Phone: (55 11) 2188-4024
E-mail: alexandre_pizano@ml.com
Marcel Moraes
Credit Suisse Phone: (55 11) 3841-6302
E-mail: marcel.moraes@credit-suisse.com
Juliana Rozenbaum - Marcio Osako
Phone: (55 11) 3073-3035 / (55 11) 3073-3040
Itaú BBA
E-mail: juliana.rozenbaum@itausecurities.com
E-mail: marcio.osako@itau.com.br
Iago Whately
Banco Fator Phone: (55 11) 3049-9480
E-mail: iwhately@bancofator.com.br
17

18. IR Contacts
Max Fischer
CFO and IR Director
Beatriz Diez
IR Manager
Telephone,: 55 (21) 4009 0276
E-mail: ri@profarma.com.br
www.profarma.com.br/ir